烏龍制藥(urgn):孕期養生心得
孕期養生心得描述::烏龍制藥(URGN):
烏龍制藥(URGN) SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000935836-22-000637 Act: 34 Size: 59 KB 網頁鏈接
烏龍制藥(URGN):
烏龍制藥(URGN) 8-K Current report, item 2.03 Accession Number: 0001193125-22-266722 Act: 34 Size: 149 KB 網頁鏈接
烏龍制藥(URGN):
烏龍制藥(URGN) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-22-026635 Size: 4 KB 網頁鏈接
烏龍制藥(URGN):
烏龍制藥(URGN) 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-22-296511 Act: 33 Size: 218 KB 網頁鏈接
烏龍制藥(URGN):
烏龍制藥(URGN) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-22-025549 Size: 8 KB 網頁鏈接
烏龍制藥(URGN):
烏龍制藥(URGN) 3 Initial statement of beneficial ownership of securities Accession Number: 0001437749-22-026636 Size: 2 KB 網頁鏈接
烏龍制藥(URGN):
烏龍制藥(URGN) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-22-024711 Size: 8 KB 網頁鏈接
烏龍制藥(URGN):
烏龍制藥(URGN) 8-K Current report, item 5.02 Accession Number: 0001193125-22-280620 Act: 34 Size: 143 KB 網頁鏈接
烏龍制藥(URGN):
烏龍制藥(URGN) 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001437749-22-026727 Act: 34 Size: 6 MB 網頁鏈接
烏龍制藥(URGN):
烏龍制藥(URGN) 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-22-281988 Act: 34 Size: 237 KB 網頁鏈接
烏龍制藥(URGN):
烏龍制藥(URGN) S-3/A [Amend] Registration statement under Securities Act of 1933 Accession Number: 0001437749-22-027542 Act: 33 Size: 96 KB 網頁鏈接
烏龍制藥(URGN):
烏龍制藥(URGN) EFFECT Notice of Effectiveness Accession Number: 9999999995-22-003411 Act: 33 Size: 1 KB 網頁鏈接